510(K) CLEARANCES 84 ▲14RECALLS POSTED 39 ▲27CLASS I 6 ▲2PMA DECISIONS 47 ▲11WEEK ENDING / FDA DATA AS OF
Medical Device
ManufacturingTHE TRADE PAPER OF THE FACTORY FLOOR
SUBSCRIBE / SIGN IN
PCNClass II

Immunoglobulin G Kappa Heavy And Light Chain Combined

21 CFR 866.5510 / Immunology
FDA source (opens on fda.gov)

PCN is the FDA product code for Immunoglobulin G Kappa Heavy And Light Chain Combined, a class II device type, regulated under 21 CFR 866.5510. FDA's definition for this code reads: "Intended for the in-vitro quantification of IgG kappa concentration in human serum". As of , FDA records hold 3 510(k) clearances under this code, the most recent dated , and no recalls.

Classification record

Product code
PCN
Device name
Immunoglobulin G Kappa Heavy And Light Chain Combined
FDA definition
Intended for the in-vitro quantification of IgG kappa concentration in human serum.
Regulation
21 CFR 866.5510
Device class
Class II
Review panel
Immunology
Submission type
510(k)
Implant
No
Life sustaining or supporting
No
GMP exempt
No
Third party review eligible
Yes
Ingested clearances
3
Ingested recalls
0

Clearances, product code PCN

By decision year
3 clearances under product code PCN with a decision year between 2013 and 2018, 2013 the highest year at 1.
Show the numbers
510(k) clearances under FDA product code PCN by decision year
YearClearances
20131
20161
20181

Applicants with the most clearances

Product code PCN
Applicants holding the most 510(k) clearances under product code PCN
ApplicantClearances
The Binding Site Group Ltd.2
The Binding Site1

Companies listing this code with FDA

Companies whose registered establishments list this code